Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 180

1.

Serial Urinary Tissue Inhibitor of Metalloproteinase-2 and Insulin-Like Growth Factor-Binding Protein 7 and the Prognosis for Acute Kidney Injury over the Course of Critical Illness.

McCullough PA, Ostermann M, Forni LG, Bihorac A, Koyner JL, Chawla LS, Shi J, Kampf JP, McPherson P, Kellum JA; the Sapphire Investigators.

Cardiorenal Med. 2019 Oct 16:1-12. doi: 10.1159/000502837. [Epub ahead of print]

PMID:
31618746
2.

Use of Cell Cycle Arrest Biomarkers in Conjunction With Classical Markers of Acute Kidney Injury.

Joannidis M, Forni LG, Haase M, Koyner J, Shi J, Kashani K, Chawla LS, Kellum JA; Sapphire Investigators.

Crit Care Med. 2019 Oct;47(10):e820-e826. doi: 10.1097/CCM.0000000000003907.

3.

Sensitivity to angiotensin II dose in patients with vasodilatory shock: a prespecified analysis of the ATHOS-3 trial.

Ham KR, Boldt DW, McCurdy MT, Busse LW, Favory R, Gong MN, Khanna AK, Chock SN, Zeng F, Chawla LS, Tidmarsh GF, Ostermann M.

Ann Intensive Care. 2019 Jun 3;9(1):63. doi: 10.1186/s13613-019-0536-5.

4.

The furosemide stress test for prediction of worsening acute kidney injury in critically ill patients: A multicenter, prospective, observational study.

Rewa OG, Bagshaw SM, Wang X, Wald R, Smith O, Shapiro J, McMahon B, Liu KD, Trevino SA, Chawla LS, Koyner JL.

J Crit Care. 2019 Aug;52:109-114. doi: 10.1016/j.jcrc.2019.04.011. Epub 2019 Apr 9.

PMID:
31035185
5.

Broad spectrum vasopressors: a new approach to the initial management of septic shock?

Chawla LS, Ostermann M, Forni L, Tidmarsh GF.

Crit Care. 2019 Apr 16;23(1):124. doi: 10.1186/s13054-019-2420-y.

6.

Therapeutic Opportunities for Hepcidin in Acute Care Medicine.

Chawla LS, Beers-Mulroy B, Tidmarsh GF.

Crit Care Clin. 2019 Apr;35(2):357-374. doi: 10.1016/j.ccc.2018.11.014. Epub 2019 Jan 30. Review.

PMID:
30784615
7.

The authors reply.

Bellomo R, Kroll S, Chawla LS, Tidmarsh GF.

Crit Care Med. 2019 Mar;47(3):e271-e272. doi: 10.1097/CCM.0000000000003601. No abstract available.

PMID:
30768522
8.

Response.

Jentzer JC, Vallabhajosyula S, Khanna AK, Chawla LS, Busse LW, Kashani KB.

Chest. 2019 Jan;155(1):242-243. doi: 10.1016/j.chest.2018.08.1069. No abstract available.

PMID:
30616731
9.

Angiotensin converting enzyme defects in shock: implications for future therapy.

Chawla LS, Chen S, Bellomo R, Tidmarsh GF.

Crit Care. 2018 Oct 28;22(1):274. doi: 10.1186/s13054-018-2202-y. No abstract available.

10.

Global epidemiology and outcomes of acute kidney injury.

Hoste EAJ, Kellum JA, Selby NM, Zarbock A, Palevsky PM, Bagshaw SM, Goldstein SL, Cerdá J, Chawla LS.

Nat Rev Nephrol. 2018 Oct;14(10):607-625. doi: 10.1038/s41581-018-0052-0. Review.

PMID:
30135570
11.

Outcomes in Patients with Vasodilatory Shock and Renal Replacement Therapy Treated with Intravenous Angiotensin II.

Tumlin JA, Murugan R, Deane AM, Ostermann M, Busse LW, Ham KR, Kashani K, Szerlip HM, Prowle JR, Bihorac A, Finkel KW, Zarbock A, Forni LG, Lynch SJ, Jensen J, Kroll S, Chawla LS, Tidmarsh GF, Bellomo R; Angiotensin II for the Treatment of High-Output Shock 3 (ATHOS-3) Investigators.

Crit Care Med. 2018 Jun;46(6):949-957. doi: 10.1097/CCM.0000000000003092. Erratum in: Crit Care Med. 2018 Aug;46(8):e824.

12.

Acute Kidney Injury Recovery.

Palant CE, Patel SS, Chawla LS.

Contrib Nephrol. 2018;193:35-44. doi: 10.1159/000484961. Epub 2018 Jan 23.

PMID:
29393153
13.

Management of Refractory Vasodilatory Shock.

Jentzer JC, Vallabhajosyula S, Khanna AK, Chawla LS, Busse LW, Kashani KB.

Chest. 2018 Aug;154(2):416-426. doi: 10.1016/j.chest.2017.12.021. Epub 2018 Jan 9. Review.

PMID:
29329694
14.

Safety and Tolerability Study of an Intravenously Administered Small Interfering Ribonucleic Acid (siRNA) Post On-Pump Cardiothoracic Surgery in Patients at Risk of Acute Kidney Injury.

Demirjian S, Ailawadi G, Polinsky M, Bitran D, Silberman S, Shernan SK, Burnier M, Hamilton M, Squiers E, Erlich S, Rothenstein D, Khan S, Chawla LS.

Kidney Int Rep. 2017 Apr 25;2(5):836-843. doi: 10.1016/j.ekir.2017.03.016. eCollection 2017 Sep.

15.

Sequelae of AKI.

Patel SS, Palant CE, Mahajan V, Chawla LS.

Best Pract Res Clin Anaesthesiol. 2017 Sep;31(3):415-425. doi: 10.1016/j.bpa.2017.08.004. Epub 2017 Sep 6. Review.

PMID:
29248147
16.

Kinetics of Urinary Cell Cycle Arrest Markers for Acute Kidney Injury Following Exposure to Potential Renal Insults.

Ostermann M, McCullough PA, Forni LG, Bagshaw SM, Joannidis M, Shi J, Kashani K, Honore PM, Chawla LS, Kellum JA; all SAPPHIRE Investigators.

Crit Care Med. 2018 Mar;46(3):375-383. doi: 10.1097/CCM.0000000000002847.

17.

The prognostic value of the furosemide stress test in predicting delayed graft function following deceased donor kidney transplantation.

McMahon BA, Koyner JL, Novick T, Menez S, Moran RA, Lonze BE, Desai N, Alasfar S, Borja M, Merritt WT, Ariyo P, Chawla LS, Kraus E.

Biomarkers. 2018 Feb;23(1):61-69. doi: 10.1080/1354750X.2017.1387934. Epub 2017 Oct 16.

18.

Drug management in acute kidney disease - Report of the Acute Disease Quality Initiative XVI meeting.

Ostermann M, Chawla LS, Forni LG, Kane-Gill SL, Kellum JA, Koyner J, Murray PT, Ronco C, Goldstein SL; ADQI 16 workgroup.

Br J Clin Pharmacol. 2018 Feb;84(2):396-403. doi: 10.1111/bcp.13449. Epub 2017 Dec 1.

19.

Angiotensin II for the Treatment of Vasodilatory Shock.

Khanna A, English SW, Wang XS, Ham K, Tumlin J, Szerlip H, Busse LW, Altaweel L, Albertson TE, Mackey C, McCurdy MT, Boldt DW, Chock S, Young PJ, Krell K, Wunderink RG, Ostermann M, Murugan R, Gong MN, Panwar R, Hästbacka J, Favory R, Venkatesh B, Thompson BT, Bellomo R, Jensen J, Kroll S, Chawla LS, Tidmarsh GF, Deane AM; ATHOS-3 Investigators.

N Engl J Med. 2017 Aug 3;377(5):419-430. doi: 10.1056/NEJMoa1704154. Epub 2017 May 21.

20.

Clinical Experience With IV Angiotensin II Administration: A Systematic Review of Safety.

Busse LW, Wang XS, Chalikonda DM, Finkel KW, Khanna AK, Szerlip HM, Yoo D, Dana SL, Chawla LS.

Crit Care Med. 2017 Aug;45(8):1285-1294. doi: 10.1097/CCM.0000000000002441. Review.

21.

Understanding renal recovery.

Bell M, Chawla LS, Wald R.

Intensive Care Med. 2017 Jun;43(6):924-926. doi: 10.1007/s00134-017-4773-5. Epub 2017 Mar 23. No abstract available.

22.

Impact of Acute Kidney Injury in Patients Hospitalized With Pneumonia.

Chawla LS, Amdur RL, Faselis C, Li P, Kimmel PL, Palant CE.

Crit Care Med. 2017 Apr;45(4):600-606. doi: 10.1097/CCM.0000000000002245.

PMID:
28291091
23.

Acute kidney disease and renal recovery: consensus report of the Acute Disease Quality Initiative (ADQI) 16 Workgroup.

Chawla LS, Bellomo R, Bihorac A, Goldstein SL, Siew ED, Bagshaw SM, Bittleman D, Cruz D, Endre Z, Fitzgerald RL, Forni L, Kane-Gill SL, Hoste E, Koyner J, Liu KD, Macedo E, Mehta R, Murray P, Nadim M, Ostermann M, Palevsky PM, Pannu N, Rosner M, Wald R, Zarbock A, Ronco C, Kellum JA; Acute Disease Quality Initiative Workgroup 16.

Nat Rev Nephrol. 2017 Apr;13(4):241-257. doi: 10.1038/nrneph.2017.2. Epub 2017 Feb 27.

PMID:
28239173
24.

Angiotensin II for the Treatment of High-Output Shock 3 (ATHOS-3): protocol for a phase III, double-blind, randomised controlled trial.

Chawla LS, Russell JA, Bagshaw SM, Shaw AD, Goldstein SL, Fink MP, Tidmarsh GF.

Crit Care Resusc. 2017 Mar;19(1):43-49.

PMID:
28215131
25.

Characterization of end-of-life electroencephalographic surges in critically ill patients.

Chawla LS, Terek M, Junker C, Akst S, Yoon B, Brasha-Mitchell E, Seneff MG.

Death Stud. 2017 Jul;41(6):385-392. doi: 10.1080/07481187.2017.1287138. Epub 2017 Feb 1.

PMID:
28145850
26.

Long-term consequences of acute kidney injury in the perioperative setting.

Palant CE, Amdur RL, Chawla LS.

Curr Opin Anaesthesiol. 2017 Feb;30(1):100-104. doi: 10.1097/ACO.0000000000000428. Review.

PMID:
27977430
27.

Use of stress tests in evaluating kidney disease.

Koyner JL, Chawla LS.

Curr Opin Nephrol Hypertens. 2017 Jan;26(1):31-35. Review.

PMID:
27820705
28.

Glomerular and Tubular Kidney Stress Test: New Tools for a Deeper Evaluation of Kidney Function.

Ronco C, Chawla LS.

Nephron. 2016;134(3):191-194. Epub 2016 Aug 30. Review.

29.

Recovery after Acute Kidney Injury.

Kellum JA, Sileanu FE, Bihorac A, Hoste EA, Chawla LS.

Am J Respir Crit Care Med. 2017 Mar 15;195(6):784-791. doi: 10.1164/rccm.201604-0799OC.

30.

ABT-719 for the Prevention of Acute Kidney Injury in Patients Undergoing High-Risk Cardiac Surgery: A Randomized Phase 2b Clinical Trial.

McCullough PA, Bennett-Guerrero E, Chawla LS, Beaver T, Mehta RL, Molitoris BA, Eldred A, Ball G, Lee HJ, Houser MT, Khan S.

J Am Heart Assoc. 2016 Aug 20;5(8). pii: e003549. doi: 10.1161/JAHA.116.003549.

31.

The Effect of Spironolactone on Acute Kidney Injury After Cardiac Surgery: A Randomized, Placebo-Controlled Trial.

Barba-Navarro R, Tapia-Silva M, Garza-Garcia C, López-Giacoman S, Melgoza-Toral I, Vázquez-Rangel A, Bazúa-Valenti S, Bobadilla N, Wasung de Lay M, Baranda F, Chawla LS, Gamba G, Madero M.

Am J Kidney Dis. 2017 Feb;69(2):192-199. doi: 10.1053/j.ajkd.2016.06.013. Epub 2016 Aug 10.

PMID:
27522513
32.

Acute appendicitis: transcript profiling of blood identifies promising biomarkers and potential underlying processes.

Chawla LS, Toma I, Davison D, Vaziri K, Lee J, Lucas R, Seneff MG, Nyhan A, McCaffrey TA.

BMC Med Genomics. 2016 Jul 15;9(1):40. doi: 10.1186/s12920-016-0200-y.

33.

Urinary Tissue Inhibitor of Metalloproteinase-2 and Insulin-Like Growth Factor-Binding Protein 7 for Risk Stratification of Acute Kidney Injury in Patients With Sepsis.

Honore PM, Nguyen HB, Gong M, Chawla LS, Bagshaw SM, Artigas A, Shi J, Joannes-Boyau O, Vincent JL, Kellum JA; Sapphire and Topaz Investigators.

Crit Care Med. 2016 Oct;44(10):1851-60. doi: 10.1097/CCM.0000000000001827.

34.

Common chronic conditions do not affect performance of cell cycle arrest biomarkers for risk stratification of acute kidney injury.

Heung M, Ortega LM, Chawla LS, Wunderink RG, Self WH, Koyner JL, Shi J, Kellum JA; Sapphire and Topaz Investigators.

Nephrol Dial Transplant. 2016 Oct;31(10):1633-40. doi: 10.1093/ndt/gfw241. Epub 2016 Jun 23.

35.

Clinical adjudication in acute kidney injury studies: findings from the pivotal TIMP-2*IGFBP7 biomarker study.

Liu KD, Vijayan A, Rosner MH, Shi J, Chawla LS, Kellum JA.

Nephrol Dial Transplant. 2016 Oct;31(10):1641-6. doi: 10.1093/ndt/gfw238. Epub 2016 Jun 23.

36.

The use of angiotensin II in distributive shock.

Chawla LS, Busse LW, Brasha-Mitchell E, Alotaibi Z.

Crit Care. 2016 May 27;20(1):137. doi: 10.1186/s13054-016-1306-5. No abstract available.

37.

High serum creatinine nonlinearity: a renal vital sign?

Palant CE, Chawla LS, Faselis C, Li P, Pallone TL, Kimmel PL, Amdur RL.

Am J Physiol Renal Physiol. 2016 Aug 1;311(2):F305-9. doi: 10.1152/ajprenal.00025.2016. Epub 2016 May 18. Review.

38.

Renal Stress Testing in the Assessment of Kidney Disease.

Chawla LS, Ronco C.

Kidney Int Rep. 2016 May 5;1(1):57-63. doi: 10.1016/j.ekir.2016.04.005. eCollection 2016 May. Review.

39.

Predicting acute kidney injury prognosis.

Szerlip HM, Chawla LS.

Curr Opin Nephrol Hypertens. 2016 May;25(3):226-31. doi: 10.1097/MNH.0000000000000223. Review.

PMID:
27023837
40.

Utilizing electronic health records to predict acute kidney injury risk and outcomes: workgroup statements from the 15(th) ADQI Consensus Conference.

Sutherland SM, Chawla LS, Kane-Gill SL, Hsu RK, Kramer AA, Goldstein SL, Kellum JA, Ronco C, Bagshaw SM; 15 ADQI Consensus Group.

Can J Kidney Health Dis. 2016 Feb 26;3:11. doi: 10.1186/s40697-016-0099-4. eCollection 2016. Review.

41.

Long-term Effects of Off-Pump Coronary Bypass Versus Conventional Coronary Bypass Grafting on Renal Function.

Hynes CF, Colo S, Amdur RL, Chawla LS, Greenberg MD, Trachiotis GD.

Innovations (Phila). 2016 Jan-Feb;11(1):54-8; discussion 58. doi: 10.1097/IMI.0000000000000224.

PMID:
26889880
42.

The Acute Kidney Injury to Chronic Kidney Disease Transition: A Potential Opportunity to Improve Care in Acute Kidney Injury.

Palant CE, Amdur RL, Chawla LS.

Contrib Nephrol. 2016;187:55-72. doi: 10.1159/000442365. Epub 2016 Feb 8. Review.

PMID:
26882009
43.

THE EPITHELIUM AS A TARGET IN SEPSIS.

Chawla LS, Fink M, Goldstein SL, Opal S, Gómez A, Murray P, Gómez H, Kellum JA; ADQI XIV Workgroup.

Shock. 2016 Mar;45(3):249-58. doi: 10.1097/SHK.0000000000000518. Review.

PMID:
26863125
44.

TIMP2•IGFBP7 biomarker panel accurately predicts acute kidney injury in high-risk surgical patients.

Gunnerson KJ, Shaw AD, Chawla LS, Bihorac A, Al-Khafaji A, Kashani K, Lissauer M, Shi J, Walker MG, Kellum JA; Sapphire Topaz investigators.

J Trauma Acute Care Surg. 2016 Feb;80(2):243-9. doi: 10.1097/TA.0000000000000912.

45.

Demographic data for urinary Acute Kidney Injury (AKI) marker [IGFBP7]·[TIMP2] reference range determinations.

Chindarkar NS, Chawla LS, Straseski JA, Jortani SA, Uettwiller-Geiger D, Orr RR, Kellum JA, Fitzgerald RL.

Data Brief. 2015 Nov 5;5:888-92. doi: 10.1016/j.dib.2015.10.036. eCollection 2015 Dec.

46.

Reference intervals of urinary acute kidney injury (AKI) markers [IGFBP7]∙[TIMP2] in apparently healthy subjects and chronic comorbid subjects without AKI.

Chindarkar NS, Chawla LS, Straseski JA, Jortani SA, Uettwiller-Geiger D, Orr RR, Kellum JA, Fitzgerald RL.

Clin Chim Acta. 2016 Jan 15;452:32-7. doi: 10.1016/j.cca.2015.10.029. Epub 2015 Nov 10.

47.

Renal Hemodynamics in AKI: In Search of New Treatment Targets.

Matejovic M, Ince C, Chawla LS, Blantz R, Molitoris BA, Rosner MH, Okusa MD, Kellum JA, Ronco C; ADQI XIII Work Group.

J Am Soc Nephrol. 2016 Jan;27(1):49-58. doi: 10.1681/ASN.2015030234. Epub 2015 Oct 28.

48.

Timing of death after traumatic injury--a contemporary assessment of the temporal distribution of death.

Valdez C, Sarani B, Young H, Amdur R, Dunne J, Chawla LS.

J Surg Res. 2016 Feb;200(2):604-9. doi: 10.1016/j.jss.2015.08.031. Epub 2015 Aug 28.

PMID:
26494012
49.

A Clinical Approach to the Acute Cardiorenal Syndrome.

Jentzer JC, Chawla LS.

Crit Care Clin. 2015 Oct;31(4):685-703. doi: 10.1016/j.ccc.2015.06.006. Review.

PMID:
26410138
50.

Acute Kidney Injury and CKD: No Respite for a Weary Kidney.

Palant C, Amdur R, Chawla LS.

Am J Kidney Dis. 2015 Oct;66(4):552-4. doi: 10.1053/j.ajkd.2015.08.014. No abstract available.

PMID:
26408233

Supplemental Content

Loading ...
Support Center